Giles Day, CEO


Jacob Glanville, CSO


Chris Smith, CTO

Giles leveraged 15 years of pharmaceutical experience to develop the unique business model that has enabled Distributed Bio to become profitable from year one

[read more]

Jake creates the science that drives Distributed Bio - he designed the core algorithms of AbGenesis, architected our antibody discovery libraries and invented the epitope focusing technology.

[read more]

Chris has architected the computational infrastructure that enables AbGenesis to reach our global client base, and enable our internal computational bioengineering programs.

[read more]